Helicos BioSciences Corporation today announced the shipment of a Helicos™ Genetic Analysis System to Stanford University for use in research.
The unique ability of the Helicos Genetic Analysis System to obtain sequence information from individual DNA molecules couples unparalleled throughput and scalability with an unbiased view of DNA and RNA that is critical for accelerating research.
About Helicos BioSciences
Helicos BioSciences is a life science company focused on innovative genetic analysis technologies for the research, drug discovery, and diagnostic markets. Helicos' proprietary True Single Molecule Sequencing (tSMS)™ technology allows direct measurement of billions of strands of DNA, enabling scientists to perform experiments and ask questions never before possible. Helicos is a recipient of the $1,000 genome grant and is committed to providing scientists the tools to unlock the era of genomic medicine. The company's corporate headquarters are located at One Kendall Square, Building 700, Cambridge, MA 02139, and its telephone number is (617) 264-1800.
Contact:
Investor Relations Contact:
Helicos BioSciences Corporation
Justine Alonzo, 617-264-1822
Investor Relations
InvestorRelations@helicosbio.com
or
Media Contact:
Ruder Finn Public Relations
Rachel Spielman, 212-583-2714 (office)
646-872-2985 (cell)
spielmanr@ruderfinn.com
Source: Helicos BioSciences Corporation
The unique ability of the Helicos Genetic Analysis System to obtain sequence information from individual DNA molecules couples unparalleled throughput and scalability with an unbiased view of DNA and RNA that is critical for accelerating research.
About Helicos BioSciences
Helicos BioSciences is a life science company focused on innovative genetic analysis technologies for the research, drug discovery, and diagnostic markets. Helicos' proprietary True Single Molecule Sequencing (tSMS)™ technology allows direct measurement of billions of strands of DNA, enabling scientists to perform experiments and ask questions never before possible. Helicos is a recipient of the $1,000 genome grant and is committed to providing scientists the tools to unlock the era of genomic medicine. The company's corporate headquarters are located at One Kendall Square, Building 700, Cambridge, MA 02139, and its telephone number is (617) 264-1800.
Contact:
Investor Relations Contact:
Helicos BioSciences Corporation
Justine Alonzo, 617-264-1822
Investor Relations
InvestorRelations@helicosbio.com
or
Media Contact:
Ruder Finn Public Relations
Rachel Spielman, 212-583-2714 (office)
646-872-2985 (cell)
spielmanr@ruderfinn.com
Source: Helicos BioSciences Corporation
0 comments:
Post a Comment